JPRN-jRCT2080223786已完成2 期
A single-dose study of TMS-007 in patients with ischemic stroke (phase IIa study)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 87age old（—）
- 性别
- All
入选标准
- •Japanese who develop symptomatic cerebral infarction
排除标准
- •1 Patients who are suitable for rt-PA or endovascular treatment
- •2 High bleeding risk
- •3 High blood pressure or high blood glucose
- •4 Severe disease affecting the pathology of ischemic stroke
- •5 Pregnancy
研究者
相似试验
未知
1 期
Phase I sutdy of TMS-007Acute ischemic strokeJPRN-jRCT2080222603TMS Co., Ltd.40
未知
2 期
Double-blind, Phase2 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Confirmatory Study of Dose-Response)Type 2 Diabetes MellitusJPRN-jRCT2080221156Taisho Pharmaceutical co., LTD275
未知
4 期
Clinical Pharmaclogical study of TS-071 in Patient With Type 2 Diabetetes Mellitus(Evaluation of glycemic variability using continuous glucose monitoring)Type 2 Diabetes MellitusJPRN-jRCT1080222497Taisho Pharmaceutical co., LTD40
已完成
1 期
Phase1 Clinical Trial of OTS102 in Subjects with Solid TumorsSolid tumorJPRN-UMIN000008336OncoTherapy Science, Inc.18
未知
Unknown
A Long-Term Clinical Study of TS-071 as Monotherapy in Patients With Type 2 Diabetes MellitusType 2 Diabetes MellitusJPRN-jRCT2080221470Taisho Pharmaceutical co., LTD300